Ascend Capital’s Insulet PODD Stock Holding History

Ascend Capital’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-242,800	Closed	-$8.1M	–	183
2015 Q1	$8.1M	Buy	+242,800	New	+$8.2M	0.28%	96

Other funds holding PODD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Ascend Capital's PODD Position: Q2 2015 in Review

Ascend Capital sold out of Insulet (PODD) in Q2 2015, closing a stake of 242,800 shares — an estimated $8.1M sold.

Ascend Capital first reported a position in PODD in Q1 2015 and held it in 1 quarter. The position peaked at $8.1M in Q1 2015. 153 funds tracked by Wall St. Rank hold PODD as of Q2 2015.

Ascend Capital reported no remaining Insulet position as of Q2 2015 after selling out during the quarter.
Ascend Capital sold 242,800 Insulet shares in Q2 2015, an estimated $8.1M.
Ascend Capital first reported a position in Insulet in Q1 2015 and held it in 1 quarter.
Ascend Capital's Insulet position peaked at $8.1M in Q1 2015.
153 funds tracked by Wall St. Rank held Insulet as of Q2 2015.

Based on Ascend Capital's 13F filing for Q2 2015, filed 13 Aug 2015.